Ostatní
Návod 
ADMA Biologics, Inc.
ADMA
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
3.4B
Obrat
1B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
49%
ROA
37%
PE
24
PS
7
Cena 1R
14-26
⌀ Cena
18.09
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
02-03-2026
Poslední dividenda
Profil
Společnost ADMA Biologics, Inc., biofarmaceutická společnost, se zabývá vývojem, výrobou a uváděním na trh speciálních biologických materiálů odvozených z plazmy pro léčbu imunitních deficitů a infekčních onemocnění ve Spojených státech a mezinárodně. Nabízí BIVIGAM, přípravek s intravenózním imunoglobulinem (IVIG) indikovaný k léčbě primárního humorálního imunodeficitu (PI); ASCENIV, přípravek IVIG k léčbě PI; a Nabi-HB k léčbě akutní expozice povrchovému antigenu hepatitidy B obsahujícímu krev a jiných uvedených expozic hepatitidě B. Společnost také vyvíjí řadu léčebných postupů odvozených z plazmy, včetně přípravků souvisejících s metodami léčby a prevence infekce S. pneumonia pro imunoglobulin. Kromě toho provozuje zařízení pro sběr zdrojové plazmy. Společnost prodává své výrobky prostřednictvím nezávislých distributorů, obchodních zástupců, specializovaných lékáren a dalších poskytovatelů alternativních lokalit. ADMA Biologics, Inc. byla založena v roce 2004 a sídlí v Ramsey v New Jersey.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
685
Založení
2013-10-17
Podobné společnosti
$ 22.42
- $ 0.15
$ 166.74
- $ 1.48
$ 112.96
- $ 0.23
$ 203.65
+ $ 1.17
$ 68.58
+ $ 0.47
$ 40.53
+ $ 0.53
$ 30.45
- $ 0.18
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 510.2 | 510.2 | 426.5 | 258.2 | 154.1 | 80.9 | 42.2 | 29.3 | 17.0 | 22.8 | 10.7 | 7.2 | 5.9 | 3.1 | 1.1 | 0.0 | 0.0 | |
| Cost of Revenues | 217.4 | 217.4 | 206.9 | 169.3 | 118.8 | 79.8 | 61.3 | 39.5 | 42.2 | 29.2 | 6.4 | 4.3 | 3.7 | 2.0 | 0.7 | 0.0 | 0.0 | |
| Gross Profit | 292.8 | 292.8 | 219.6 | 88.9 | 35.3 | 1.2 | -19.1 | -10.2 | -25.2 | -6.4 | 4.3 | 2.9 | 2.2 | 1.0 | 0.4 | 0.0 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 139.2 | 134.2 | 122.0 | 114.8 | 117.5 | 119.8 | 107.2 | 81.9 | 73.9 | 67.3 | |
| Cost of Revenues | 50.3 | 58.6 | 54.8 | 53.7 | 54.2 | 60.2 | 49.7 | 42.8 | 43.0 | 42.6 | |
| Gross Profit | 88.8 | 75.6 | 67.2 | 61.1 | 63.3 | 59.7 | 57.5 | 39.1 | 30.9 | 24.7 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 3.3 | 3.6 | 3.6 | 5.9 | 2.3 | 3.9 | 6.2 | 7.7 | 7.0 | 9.5 | 9.3 | 3.5 | 0.0 | 0.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 59.0 | 52.5 | 42.9 | 35.1 | 25.9 | 22.5 | 18.1 | 8.5 | 6.7 | 4.8 | 4.4 | 3.1 | 0.0 | 0.0 | |
| Depreciation & Amortization | 8.1 | 8.1 | 8.0 | 8.3 | 0.1 | 0.5 | 0.9 | 1.4 | 3.4 | 1.2 | 0.5 | 0.5 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | |
| Total Operating Expenses | 101.3 | 101.3 | 80.6 | 66.6 | 74.6 | 59.5 | 45.8 | 31.3 | 35.1 | 32.1 | 21.6 | 18.4 | 18.2 | 16.1 | 8.4 | 0.0 | 0.0 | |
| Operating Income | 191.4 | 191.4 | 139.0 | 21.6 | -39.4 | -58.4 | -64.9 | -41.4 | -60.3 | -39.3 | -17.3 | -15.5 | -16.0 | -15.0 | -7.9 | 0.0 | 0.0 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.6 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 16.2 | 14.7 | ||
| Depreciation & Amortization | 2.0 | 2.0 | 2.1 | 2.0 | 1.9 | 1.9 | 2.0 | 2.1 | 2.1 | 2.1 | ||
| Total Operating Expenses | 26.1 | 24.6 | 24.4 | 26.2 | 25.0 | 20.0 | 18.3 | 17.3 | 16.7 | 16.0 | ||
| Operating Income | 62.8 | 51.0 | 42.8 | 34.9 | 38.3 | 39.6 | 39.2 | 21.8 | 14.2 | 8.7 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 1.9 | 1.9 | 2.1 | 1.6 | 0.0 | 0.0 | 0.3 | 0.8 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 7.1 | 7.1 | 13.9 | 25.0 | 19.3 | 13.1 | 12.0 | 9.0 | 5.5 | 3.3 | 2.2 | 1.8 | 1.3 | 0.6 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -8.8 | -8.8 | -13.3 | -49.9 | -26.5 | -13.3 | -10.8 | -6.9 | -0.1 | -2.1 | 0.0 | -0.7 | -0.1 | 0.1 | -1.7 | 0.0 | 0.0 | |
| IBT | 182.7 | 182.7 | 125.7 | -28.2 | -65.9 | -71.6 | -75.7 | -48.3 | -65.7 | -43.8 | -19.5 | -18.0 | -17.4 | -15.5 | -7.9 | 0.0 | 0.0 | |
| Income Tax Expense | 35.7 | 35.7 | -72.0 | 0.0 | 19.3 | 12.8 | 11.9 | 8.8 | 5.5 | 4.4 | 2.2 | 2.5 | -0.6 | 0.5 | -0.6 | 0.0 | 0.0 | |
| Net Income | 146.9 | 146.9 | 197.7 | -28.2 | -85.2 | -84.5 | -87.6 | -57.0 | -65.7 | -43.8 | -19.5 | -18.0 | -16.8 | -15.5 | -7.3 | 0.0 | 0.0 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.5 | 0.4 | 0.4 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.4 | ||
| Interest Expense | 1.6 | 1.7 | 1.8 | 2.0 | 2.9 | 3.5 | 3.8 | 3.8 | 6.2 | 6.4 | ||
| Other Expense | -1.2 | -3.5 | -2.7 | -1.4 | -3.6 | -2.9 | -3.4 | -3.4 | -31.9 | -6.1 | ||
| IBT | 61.6 | 47.5 | 40.1 | 33.5 | 34.7 | 36.7 | 35.9 | 18.4 | -17.6 | 2.6 | ||
| Income Tax Expense | 12.2 | 11.1 | 5.9 | 6.5 | -77.2 | 0.8 | 3.8 | 0.6 | 0.0 | 6.3 | ||
| Net Income | 49.4 | 36.4 | 34.2 | 26.9 | 111.9 | 35.9 | 32.1 | 17.8 | -17.6 | 2.6 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.13 | $-0.43 | $-0.61 | $-1.02 | $-1.05 | $-1.45 | $-1.91 | $-1.61 | $-1.73 | $-1.81 | $-2.38 | $-1.39 | $-0.01 | $-0.01 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.13 | $-0.43 | $-0.61 | $-1.02 | $-1.05 | $-1.45 | $-1.91 | $-1.61 | $-1.73 | $-1.81 | $-2.38 | $-1.39 | $-0.01 | $-0.01 | |
| Shares Outstanding | 238.0 | 238.3 | 233.1 | 224.0 | 197.9 | 139.6 | 86.1 | 54.3 | 45.2 | 22.9 | 12.2 | 10.4 | 9.3 | 6.5 | 5.3 | 2.5 | 2.5 | |
| Diluted Shares Outstanding | 243.9 | 244.9 | 243.3 | 224.0 | 197.9 | 139.6 | 86.1 | 54.3 | 45.2 | 22.9 | 12.2 | 10.4 | 9.3 | 6.5 | 5.3 | 2.5 | 2.5 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.08 | $0.01 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.08 | $0.01 | ||
| Shares Outstanding | 238.0 | 238.6 | 241.5 | 237.8 | 236.4 | 234.6 | 232.4 | 228.9 | 226.0 | 225.3 | ||
| Diluted Shares Outstanding | 243.9 | 244.7 | 248.6 | 244.7 | 245.9 | 244.8 | 242.2 | 236.4 | 226.0 | 233.8 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 88.2 | 103.1 | 51.4 | 86.5 | 51.1 | 55.9 | 26.8 | 22.8 | 43.1 | 9.9 | 10.4 | 17.2 | 26.1 | 12.5 | 0.0 | 0.0 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.4 | 6.4 | 4.7 | 2.9 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 88.2 | 103.1 | 51.4 | 86.5 | 51.1 | 55.9 | 26.8 | 22.8 | 43.1 | 15.3 | 16.8 | 21.9 | 29.1 | 12.5 | 0.0 | 0.0 | |
| Accounts Receivable | 30.1 | 50.0 | 27.4 | 15.5 | 28.6 | 13.2 | 3.5 | 1.4 | 3.9 | 1.0 | 0.9 | 0.4 | 0.0 | 0.0 | 0.0 | -3.5 | |
| Inventory | 179.8 | 170.2 | 172.9 | 163.3 | 124.7 | 81.5 | 53.1 | 18.6 | 12.6 | 5.0 | 3.4 | 1.7 | 1.7 | 1.3 | 0.0 | 3.4 | |
| Other Current Assets | 5.5 | 8.0 | 5.3 | 5.1 | 4.3 | 3.0 | 2.5 | 1.8 | 2.1 | 0.3 | 0.1 | 0.1 | 0.3 | 0.1 | 0.0 | 0.1 | |
| Total Current Assets | 303.7 | 331.4 | 257.0 | 270.4 | 208.7 | 153.7 | 85.8 | 44.5 | 63.2 | 21.7 | 21.3 | 24.1 | 31.1 | 13.9 | 0.0 | 0.0 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 61.4 | 90.3 | 71.6 | 103.1 | 86.7 | 88.2 | 45.3 | 51.4 | 74.2 | 62.5 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 61.4 | 90.3 | 71.6 | 103.1 | 86.7 | 88.2 | 45.3 | 51.4 | 74.2 | 62.5 | |
| Accounts Receivable | 137.7 | 109.7 | 99.4 | 50.0 | 50.1 | 30.1 | 49.6 | 27.4 | 31.3 | 36.7 | |
| Inventory | 196.7 | 191.5 | 172.2 | 170.2 | 171.8 | 179.8 | 177.7 | 172.9 | 163.1 | 161.8 | |
| Other Current Assets | 6.9 | 8.1 | 8.6 | 8.0 | 9.5 | 5.5 | 3.7 | 5.3 | 5.1 | 5.2 | |
| Total Current Assets | 402.7 | 399.6 | 351.8 | 331.4 | 318.2 | 303.7 | 276.4 | 257.0 | 273.7 | 266.2 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 63.5 | 63.3 | 63.5 | 68.7 | 58.2 | 45.9 | 31.7 | 30.1 | 30.5 | 2.0 | 2.4 | 2.8 | 0.8 | 0.8 | 0.0 | 1.1 | |
| Goodwill | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.5 | 0.5 | 0.5 | 1.0 | 1.7 | 2.4 | 3.2 | 4.0 | 4.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | |
| Other Long-Term Assets | 5.2 | 5.7 | 4.7 | 4.8 | 4.1 | 2.1 | 2.8 | 6.7 | 6.0 | 0.0 | 0.0 | 0.3 | 0.2 | -12.7 | 0.0 | 0.0 | |
| Total Long-Term Assets | 72.7 | 157.3 | 72.2 | 78.1 | 67.5 | 53.9 | 41.3 | 44.3 | 44.9 | 2.0 | 2.4 | 3.1 | 0.9 | 1.6 | 0.0 | 1.5 | |
| Total Assets | 376.4 | 488.7 | 329.2 | 348.5 | 276.3 | 207.7 | 127.1 | 88.9 | 108.0 | 23.7 | 23.7 | 27.2 | 32.0 | 15.6 | 0.0 | 0.0 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 78.8 | 66.5 | 65.7 | 63.3 | 53.7 | 63.5 | 64.7 | 63.5 | 64.6 | 66.3 | |
| Goodwill | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | |
| Intangible Assets | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.3 | 0.5 | 0.5 | 0.7 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 8.8 | 9.1 | 8.2 | 5.7 | 14.7 | 5.2 | 5.9 | 4.7 | 6.7 | 6.3 | |
| Total Long-Term Assets | 166.0 | 158.8 | 158.8 | 157.3 | 72.4 | 72.7 | 74.5 | 72.2 | 75.3 | 76.8 | |
| Total Assets | 568.7 | 558.4 | 510.6 | 488.7 | 390.6 | 376.4 | 350.9 | 329.2 | 349.0 | 343.0 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 14.2 | 20.2 | 15.7 | 13.2 | 12.4 | 11.1 | 9.2 | 5.9 | 5.9 | 2.6 | 2.1 | 1.8 | 2.7 | 1.1 | 0.0 | 0.8 | |
| Short-Term Debt | 1.1 | 1.2 | 0.9 | 0.9 | 0.6 | 0.4 | 0.2 | 0.0 | 3.3 | 6.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 27.7 | 30.5 | 32.9 | 25.0 | 17.2 | 8.4 | 4.5 | 3.6 | 0.1 | 2.4 | 2.0 | 2.3 | 0.9 | 0.7 | 0.0 | -0.8 | |
| Current Liabilities | 44.2 | 55.5 | 49.8 | 39.3 | 30.4 | 19.9 | 14.0 | 9.6 | 9.4 | 11.2 | 4.2 | 4.2 | 3.7 | 1.8 | 0.0 | 0.0 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 24.0 | 29.8 | 20.6 | 20.2 | 16.0 | 14.2 | 17.2 | 15.7 | 10.9 | 12.1 | |
| Short-Term Debt | 3.6 | 1.1 | 1.2 | 1.2 | 1.2 | 1.1 | 1.1 | 1.0 | 2.0 | 2.0 | |
| Other Current Liabilities | 28.8 | 41.2 | 25.0 | 30.5 | 27.5 | 24.9 | 33.7 | 32.9 | 28.9 | 27.8 | |
| Current Liabilities | 56.5 | 74.9 | 53.5 | 55.5 | 44.9 | 44.2 | 53.1 | 49.8 | 41.8 | 42.0 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 131.1 | 80.9 | 140.4 | 153.5 | 102.3 | 97.3 | 84.5 | 44.2 | 43.0 | 14.1 | 15.7 | 15.0 | 5.1 | 4.0 | 0.0 | 0.1 | |
| Capital Leases | 9.2 | 9.8 | 10.8 | 11.6 | 8.1 | 4.7 | 1.5 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Def. Tax Liability | 9.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -40.5 | 0.0 | -8.0 | -16.3 | 0.1 | -3.8 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 188.1 | 139.7 | 194.0 | 196.5 | 135.1 | 119.4 | 100.9 | 69.1 | 67.7 | 28.1 | 22.9 | 21.2 | 10.4 | 6.1 | 0.0 | 0.0 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 79.5 | 82.7 | 80.8 | 80.9 | 110.2 | 140.3 | 140.3 | 140.4 | 152.0 | 150.5 | |
| Capital Leases | 0.0 | 10.4 | 9.5 | 9.8 | 10.1 | 10.3 | 10.6 | 9.8 | 10.9 | 11.2 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 9.8 | 0.0 | 0.0 | |
| Total Liabilities | 137.5 | 160.1 | 137.2 | 139.7 | 158.7 | 188.1 | 197.2 | 194.0 | 197.6 | 196.3 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -456.4 | -308.6 | -506.3 | -478.0 | -412.1 | -340.5 | -264.7 | -216.4 | -150.7 | -106.9 | -87.4 | -69.4 | -52.6 | -37.1 | -0.1 | -0.1 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.4 | -1.3 | -2.2 | -1.8 | -1.3 | -1.0 | 0.0 | 0.0 | -0.5 | |
| Total Common Equity | 188.3 | 349.0 | 135.2 | 152.0 | 141.2 | 88.2 | 26.2 | 19.8 | 40.3 | -4.5 | 0.8 | 6.0 | 21.6 | 9.4 | 0.0 | 0.0 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -211.0 | -247.5 | -281.7 | -308.6 | -420.5 | -456.4 | -488.5 | -506.3 | -488.6 | -491.2 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 431.2 | 398.3 | 373.4 | 349.0 | 231.9 | 188.3 | 153.7 | 135.2 | 151.4 | 146.8 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 141.4 | 82.1 | 141.4 | 154.4 | 102.9 | 97.7 | 84.7 | 44.2 | 43.0 | 20.3 | 15.7 | 15.0 | 5.1 | 4.0 | 9.8 | 7.2 | |
| Book Value | 188.3 | 349.0 | 135.2 | 152.0 | 141.2 | 88.2 | 26.2 | 19.8 | 40.3 | -4.5 | 0.8 | 6.0 | 21.6 | 9.4 | 0.0 | 0.0 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 431.2 | 398.3 | 373.4 | 349.0 | 231.9 | 188.3 | 153.7 | 135.2 | 151.4 | 146.8 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 34.8 | 146.9 | 197.7 | -28.2 | -65.9 | -71.6 | -75.7 | -48.3 | -65.7 | -43.8 | -19.5 | -18.0 | -16.8 | -15.5 | -7.3 | 0.0 | 0.0 | |
| Depreciation & Amortization | 8.4 | 8.1 | 8.0 | 8.3 | 7.1 | 5.5 | 3.9 | 3.3 | 3.4 | 2.7 | 0.5 | 0.5 | 0.2 | 0.2 | 0.2 | 0.0 | 0.2 | |
| Stock-Based Compensation | 8.4 | 20.0 | 13.6 | 6.2 | 5.2 | 3.5 | 2.9 | 2.7 | 2.2 | 1.6 | 1.3 | 1.7 | 1.2 | 0.9 | 0.6 | 0.0 | 0.0 | |
| Change Working Capital | -8.6 | -139.6 | -18.5 | -10.1 | -18.3 | -51.7 | -33.8 | -33.5 | -3.7 | -0.3 | -1.0 | -0.7 | 0.2 | 3.4 | -0.4 | 0.0 | 0.0 | |
| Change In Accounts Receivable | 6.6 | -108.4 | -22.6 | -11.9 | 13.1 | -15.3 | -9.8 | -2.1 | 2.5 | -2.9 | -0.1 | -0.5 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 3.6 | 2.3 | 4.2 | 3.8 | 0.8 | 1.4 | 1.9 | 3.3 | 0.0 | 2.8 | 0.5 | 0.3 | -0.9 | 1.6 | -0.2 | 0.0 | 0.0 | |
| Change In Inventories | -18.0 | -36.2 | 2.7 | -9.6 | -38.6 | -43.2 | -28.5 | -34.7 | -6.0 | 0.6 | -1.6 | -1.7 | 0.0 | -0.4 | -0.1 | 0.0 | 0.0 | |
| Other Non-cash Items | 61.1 | 3.9 | 2.2 | 32.6 | 12.4 | 1.8 | 1.6 | 1.0 | 1.0 | 0.6 | 0.5 | 0.4 | 0.4 | 0.1 | 0.0 | 0.0 | -0.2 | |
| Cash from Operations | 73.0 | 0.0 | 0.0 | 8.8 | -59.5 | -112.4 | -102.0 | -76.2 | -62.7 | -37.3 | -18.3 | -15.4 | -14.7 | -10.9 | -6.9 | 0.0 | 0.0 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 49.4 | 36.4 | 34.2 | 26.9 | 111.9 | 35.9 | 32.1 | 17.8 | -17.6 | 2.6 | |
| Depreciation & Amortization | 2.0 | 2.0 | 2.1 | 2.2 | 2.2 | 1.9 | 2.3 | 2.4 | 2.1 | 2.1 | |
| Stock-Based Compensation | 5.4 | 5.0 | 5.0 | 4.6 | 5.4 | 0.0 | 2.9 | 2.1 | 1.7 | 1.7 | |
| Change Working Capital | -22.5 | -37.3 | -23.0 | -56.9 | 9.8 | -16.2 | 10.3 | -25.0 | 3.6 | 3.9 | |
| Change In Accounts Receivable | -20.8 | -27.9 | -10.3 | -49.4 | 0.1 | -20.0 | 19.5 | -22.2 | 3.9 | 5.4 | |
| Change In Accounts Payable | -2.2 | -4.9 | 9.3 | 0.0 | 0.0 | 1.6 | 0.0 | 0.0 | 5.0 | 0.0 | |
| Change In Inventories | -9.8 | -5.2 | -19.3 | -2.0 | 1.6 | 8.0 | -2.1 | -4.8 | -9.8 | -1.3 | |
| Other Non-cash Items | 0.2 | 2.3 | 1.3 | 3.5 | -79.1 | 3.4 | -1.9 | 0.4 | 34.6 | 1.7 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 17.6 | 12.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -6.9 | -22.6 | -8.2 | -4.8 | -13.9 | -13.5 | -12.7 | -3.8 | -2.1 | -2.7 | -0.1 | 0.0 | -2.3 | -0.2 | -0.1 | 0.0 | 0.0 | |
| Acquisitions | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 12.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -12.5 | -15.7 | -1.7 | -1.7 | -2.9 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.4 | 16.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | -0.2 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 12.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -6.9 | 0.0 | 0.0 | -5.0 | -13.9 | -13.5 | -12.7 | -3.8 | -2.1 | 15.2 | 0.9 | -1.7 | -4.0 | -3.1 | -0.1 | 0.0 | 0.0 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -1.1 | -14.4 | -2.4 | -4.7 | -2.8 | -1.1 | -2.1 | -2.3 | -1.4 | -0.8 | |
| Acquisitions | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.4 | -0.8 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -38.7 | 0.0 | 0.0 | -23.6 | -100.0 | 0.0 | -14.0 | -30.0 | 0.0 | -20.0 | 0.0 | -15.3 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | |
| Debt Issued | 28.5 | 82.1 | -59.3 | 10.6 | 151.6 | 5.3 | 26.9 | 70.5 | 1.3 | 42.7 | 4.5 | 16.1 | 9.9 | 1.1 | -5.6 | 2.6 | 7.2 | |
| Issuance of Common Stock | 2.0 | 0.0 | 0.0 | 0.0 | 64.6 | 121.1 | 131.2 | 48.4 | 42.9 | 39.2 | 14.1 | 10.3 | 0.0 | 27.0 | 17.3 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -3.0 | -31.9 | 0.0 | -1.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.9 | 0.0 | 0.0 | |
| Other Financing Activities | -3.7 | 0.0 | 0.0 | -14.0 | 144.2 | -0.1 | 26.7 | 61.6 | 0.0 | 41.6 | 2.7 | 15.5 | 9.8 | 0.6 | 6.4 | 0.0 | 0.0 | |
| Cash from Financing | -40.4 | 0.0 | 0.0 | -39.0 | 108.9 | 121.0 | 143.9 | 80.0 | 42.9 | 60.8 | 16.8 | 10.4 | 9.8 | 27.6 | 19.5 | 0.0 | 0.0 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -23.6 | 0.0 | |
| Debt Issued | 83.1 | -0.7 | 1.8 | -0.1 | -29.3 | -30.0 | 0.0 | 0.0 | 12.0 | 1.5 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | |
| Repurchase of Common Stock | -8.9 | -23.0 | 0.0 | -7.2 | -0.6 | 0.0 | -0.7 | -2.5 | 0.0 | -0.2 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -15.1 | 0.4 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -39.0 | 0.4 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 25.7 | -15.5 | 51.8 | -35.2 | 35.4 | -4.8 | 29.2 | 0.0 | -21.9 | 38.7 | -0.5 | -6.8 | -9.0 | 13.6 | 12.4 | 0.0 | 0.0 | |
| Closing Cash Balance | 88.2 | 87.6 | 103.1 | 51.4 | 86.5 | 51.1 | 55.9 | 26.8 | 26.8 | 48.6 | 9.9 | 10.4 | 17.2 | 26.1 | 12.5 | 0.0 | 0.0 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 26.2 | -28.9 | 18.7 | -31.5 | 16.4 | -1.5 | 42.9 | -6.0 | -22.8 | 11.6 | |
| Closing Cash Balance | 87.6 | 61.4 | 90.3 | 71.6 | 103.1 | 86.7 | 88.2 | 45.3 | 51.4 | 74.2 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 66.1 | 27.8 | 110.1 | 3.8 | -73.4 | -125.9 | -114.7 | -80.0 | -64.8 | -39.9 | -18.3 | -15.4 | -17.0 | -11.1 | -7.0 | 0.0 | 0.0 | |
| Real Free Cash Flow | 57.7 | 7.8 | 96.5 | -2.4 | -78.6 | -129.4 | -117.6 | -82.7 | -67.0 | -41.5 | -19.6 | -17.2 | -18.3 | -12.0 | -7.6 | 0.0 | 0.0 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 34.6 | -1.1 | 18.7 | -24.4 | 47.5 | 24.0 | 43.6 | -4.6 | 16.2 | 11.2 | |
| Real Free Cash Flow | 29.2 | -6.1 | 13.8 | -29.0 | 42.0 | 24.0 | 40.7 | -6.7 | 14.4 | 9.5 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 23.8 | -7.7 | -1.4 |
| P/S | 6.8 | 8.3 | 9.4 |
| P/B | 8.1 | -3.9 | 5.2 |
| P/FCF | 448 | 18.1 | -1.5 |
| Market cap | $3.4 | $12.6 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 14.6 % | 6652.6 % | 0 % |
| Debt to Income | 56.6 % | -6183.4 % | 0 % |
| Debt to Free cash flow | 1066.4 % | -265.3 % | 0 % |
| Interest expense percentage | 3.7 % | 20.3 % | 44.7 % |
| Current ratio | 7.1 | 6 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 34.1 % | 220.8 % | 0 % |
| ROA | 25.8 % | -70.4 % | 0 % |
| CapEx to Revenue | 5 % | 9.6 % | 0 % |
| RaD to Revenue | 0 % | 95.6 % | 0 % |
| ROEM | 425,144.2 | 68173.4 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 54.7 % | 3.8 % | 68.7 % |
| Operating margin | 34.2 % | -640 % | 35.5 % |
| Net margin | 42.9 % | -423.9 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 244.7 mil | 76.5 mil |
| Employee count | 1.2 tis | 0.3 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
